Loading clinical trials...
Loading clinical trials...
Comprehensive Registry of Left Main Coronary Artery Percutaneous Coronary Intervention Outcomes at Istanbul Medipol University Hospital
This hospital-based registry study at Istanbul Medipol University Hospital focuses on documenting and analyzing the clinical and demographic characteristics, procedural-related aspects, and both short and long-term outcomes of patients undergoing left main coronary artery percutaneous coronary intervention (PCI). The study aims to identify predictors for adverse clinical outcomes in patients treated for left main coronary artery disease.
Age
18 - 80 years
Sex
ALL
Healthy Volunteers
No
Istanbul Medipol University
Istanbul, Turkey (Türkiye)
Start Date
June 1, 2018
Primary Completion Date
December 31, 2022
Completion Date
December 31, 2023
Last Updated
February 16, 2024
3,620
ACTUAL participants
Percutaneous coronary intervention
DEVICE
Lead Sponsor
Medipol University
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT01311323